| Product Code: ETC9510967 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Suriname experienced a significant surge in encephalitis vaccine imports in 2024, with top suppliers being the United States, Trinidad and Tobago, Brazil, and the Netherlands. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, while the impressive compound annual growth rate (CAGR) of 23.24% from 2020 to 2024 highlights the growing demand for vaccines in the region. The exceptional growth rate of 81.21% from 2023 to 2024 suggests a rapid acceleration in vaccine imports, possibly driven by increased awareness or public health initiatives in Suriname.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Encephalitis Vaccine Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Encephalitis Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Encephalitis Vaccine Market - Industry Life Cycle |
3.4 Suriname Encephalitis Vaccine Market - Porter's Five Forces |
3.5 Suriname Encephalitis Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Suriname Encephalitis Vaccine Market Revenues & Volume Share, By Strain, 2021 & 2031F |
3.7 Suriname Encephalitis Vaccine Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Suriname Encephalitis Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing encephalitis |
4.2.2 Growing government initiatives to promote vaccination programs |
4.2.3 Rising incidence of encephalitis cases in Suriname |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas of Suriname |
4.3.2 High cost associated with the development and distribution of vaccines |
4.3.3 Regulatory challenges and stringent approval processes for new vaccines |
5 Suriname Encephalitis Vaccine Market Trends |
6 Suriname Encephalitis Vaccine Market, By Types |
6.1 Suriname Encephalitis Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Encephalitis Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Suriname Encephalitis Vaccine Market Revenues & Volume, By Mouse Brain-Derived, Inactivated Vaccine, 2021- 2031F |
6.1.4 Suriname Encephalitis Vaccine Market Revenues & Volume, By Cell Culture-Derived, Inactivated Vaccine, 2021- 2031F |
6.1.5 Suriname Encephalitis Vaccine Market Revenues & Volume, By Cell Culture-Derived, Live Attenuated Vaccine, 2021- 2031F |
6.2 Suriname Encephalitis Vaccine Market, By Strain |
6.2.1 Overview and Analysis |
6.2.2 Suriname Encephalitis Vaccine Market Revenues & Volume, By Nakayama, 2021- 2031F |
6.2.3 Suriname Encephalitis Vaccine Market Revenues & Volume, By Beijing, 2021- 2031F |
6.2.4 Suriname Encephalitis Vaccine Market Revenues & Volume, By P-3, 2021- 2031F |
6.2.5 Suriname Encephalitis Vaccine Market Revenues & Volume, By SA14-14-2, 2021- 2031F |
6.3 Suriname Encephalitis Vaccine Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 Suriname Encephalitis Vaccine Market Revenues & Volume, By Child, 2021- 2031F |
6.3.3 Suriname Encephalitis Vaccine Market Revenues & Volume, By Adult, 2021- 2031F |
7 Suriname Encephalitis Vaccine Market Import-Export Trade Statistics |
7.1 Suriname Encephalitis Vaccine Market Export to Major Countries |
7.2 Suriname Encephalitis Vaccine Market Imports from Major Countries |
8 Suriname Encephalitis Vaccine Market Key Performance Indicators |
8.1 Number of vaccination campaigns conducted in Suriname |
8.2 Percentage increase in vaccination coverage rates |
8.3 Research and development investment in encephalitis vaccines |
9 Suriname Encephalitis Vaccine Market - Opportunity Assessment |
9.1 Suriname Encephalitis Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Suriname Encephalitis Vaccine Market Opportunity Assessment, By Strain, 2021 & 2031F |
9.3 Suriname Encephalitis Vaccine Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Suriname Encephalitis Vaccine Market - Competitive Landscape |
10.1 Suriname Encephalitis Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Suriname Encephalitis Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here